97.18K
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Medical - Pharmaceuticals
Industry

Avisa Diagnostics Inc. operates a clinical-stage medical device company. It is developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its proprietary drug substrates. The company offers clinical proof-of-concept through trials in cystic fibrosis, tuberculosis, and communityacquired pneumonia.

Similar securities

Based on sector and market capitalization

Report issue